N
NURX
Telemedicine platform focused on birth control and HIV prevention
About NURX
Nurx operates in the telehealth sector, offering a convenient and affordable way for individuals to access healthcare services online. The company primarily serves clients who require birth control, genital herpes treatment, and other prescription medications. Nurx's business model revolves around connecting patients with licensed medical professionals who can prescribe medications and provide guidance without the need for in-person visits. The company generates revenue through the sale of prescription medications and home testing kits, which are delivered directly to the client's door. Nurx also offers automatic refills and renewals, ensuring continuous coverage for their clients. The market Nurx operates in includes individuals seeking accessible and cost-effective healthcare solutions, particularly those who may not have easy access to traditional healthcare services or prefer the convenience of online consultations. The company aims to make healthcare easy, affordable, and accessible, with or without insurance coverage.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2015
- Headquarters
- New York City, United States
- Employees
- 113
- Open positions
- None listed
- Dealroom signal
- 65.0/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Personal Health, Pharmacy, Direct-to-Consumer, Sustainable Development Goals, Sextech, Tech for Patients, Hard Tech, YC W16
- Client focus
- b2c
- Investment activity
- 1 company, latest Feb 2022
- Capital deployed
- —
- Preferred round
- MERGER
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| MERGEROther financing | Feb 2022 | $0 | — | Thirty Madison | ↗ |
| SERIES COther financing | Aug 2020 | $23M | $268M | Union Square Ventures · Trustbridge · Trustbridge Partners · Kleiner Perkins | — |
Growth signals
Latest recorded traffic for NURX is 1.1M monthly website visits, up 10% over the last three months. NURX's team declined 8.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Thirty MadisonNew York City, United StatesThirty Madison is a family of specialized healthcare brands creating exceptional outcomes for all
$500Mvaluation
RenteradarOslo, NorwayBeste boliglånsrente | Sammenlign rente på boliglån | Renteradar.no
$8.7Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Y Combinator
Panos Papadopoulos
Series A8 investors entered at this stage
Series B and later4 investors entered at this stage
Trustbridge Partners
Comcast Ventures
Wittington Ventures
Trustbridge
Other known investors1 additional known investor
- Thirty Madison
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NURX on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NURX’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.